KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

News
May 11, 2026
Kentucky’s hospitals are not only essential pillars of high-quality care — they are also among the Commonwealth’s most powerful economic engines, generating $34 billion in economic activity each year, according to a new report from the Kentucky Hospital Association.
News
May 6, 2026
The KHA Quality Team is proud to congratulate our newest KHA Patient Safety Hero!
News
May 5, 2026
Kentucky hospitals are expanding a new model of patient care that treats food as a critical part of medicine, following passage of Senate Joint Resolution 23 earlier this month.